SCHEMBL23516843

SCHEMBL23516843

CC(C)CC[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccc(C(F)(F)F)cc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 16/20 0.82
PSMB9 P28065 2/20 0.82
PSMB8 P28062 2/20 0.82
PSMB10 P40306 2/20 0.82
PSMB2 P49721 2/20 0.82
PSMB11 A5LHX3 1/20 0.82
PSMD11 O00231 1/20 0.82
PSMD12 O00232 1/20 0.82
PSMD14 O00487 1/20 0.82
PSMA7 O14818 1/20 0.82
PSMD3 O43242 1/20 0.82
CTSB P07858 1/20 0.82
CYP3A4 P08684 1/20 0.82
PSMC3 P17980 1/20 0.82
PSMB1 P20618 1/20 0.82
CYP3A5 P20815 1/20 0.82
CYP3A7 P24462 1/20 0.82
PSMA1 P25786 1/20 0.82
PSMA2 P25787 1/20 0.82
PSMA3 P25788 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22545301 1.00 PSMB5 (0.82) PSMB5PSMB9PSMB8PSMB10PSMB2
SCHEMBL20284325 0.97 PSMB5 (0.87) PSMB5PSMB9PSMB8PSMB10PSMB2
SCHEMBL8267299 0.97 PSMB5 (0.87) PSMB5PSMB9PSMB8PSMB10PSMB2
SCHEMBL20284367 0.97 PSMB5 (0.87) PSMB5PSMB9PSMB8PSMB10PSMB2
SCHEMBL19289764 0.97 PSMB5 (0.87) PSMB5PSMB9PSMB8PSMB10PSMB2
SCHEMBL21035434 0.94 PSMB5 (0.94) PSMB5PSMB9PSMB8PSMB10PSMB2
SCHEMBL20825301 0.94 PSMB5 (0.94) PSMB5PSMB9PSMB8PSMB10PSMB2
SCHEMBL21036169 0.94 PSMB5 (0.94) PSMB5PSMB9PSMB8PSMB10PSMB2
SCHEMBL20877888 0.94 PSMB5 (0.94) PSMB5PSMB9PSMB8PSMB10PSMB2
SCHEMBL21036020 0.94 PSMB5 (0.94) PSMB5PSMB9PSMB8PSMB10PSMB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210179663-A1 COMPOUNDS FOR PROTEASOME ENZYME INHIBITION PROTEOLIX, INC. 2021-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210179663-A1 COMPOUNDS FOR PROTEASOME ENZYME INHIBITION PSMB1, PSMB9, PSMB3 PSMB5 14/4885PSMB9 2/4885PSMB8 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.